Albert Batalla

3.4k total citations
61 papers, 1.6k citations indexed

About

Albert Batalla is a scholar working on Pharmacology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Albert Batalla has authored 61 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pharmacology, 21 papers in Psychiatry and Mental health and 20 papers in Cellular and Molecular Neuroscience. Recurrent topics in Albert Batalla's work include Cannabis and Cannabinoid Research (21 papers), Schizophrenia research and treatment (15 papers) and Neurotransmitter Receptor Influence on Behavior (14 papers). Albert Batalla is often cited by papers focused on Cannabis and Cannabinoid Research (21 papers), Schizophrenia research and treatment (15 papers) and Neurotransmitter Receptor Influence on Behavior (14 papers). Albert Batalla collaborates with scholars based in Netherlands, Spain and United Kingdom. Albert Batalla's co-authors include Rocı́o Martı́n-Santos, Magı́ Farré, Sagnik Bhattacharyya, Matthijs G. Bossong, Murat Yücel, Marta Torrens, Santiago Nogué, Jesús Pujol, Paolo Fusar‐Poli and José Alexandre S. Crippa and has published in prestigious journals such as PLoS ONE, Neuroscience & Biobehavioral Reviews and The British Journal of Psychiatry.

In The Last Decade

Albert Batalla

54 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Albert Batalla Netherlands 23 897 444 389 358 239 61 1.6k
James J. Mahoney United States 27 437 0.5× 901 2.0× 331 0.9× 314 0.9× 335 1.4× 88 2.0k
Fergus Kane United Kingdom 17 360 0.4× 202 0.5× 380 1.0× 410 1.1× 184 0.8× 28 1.3k
Raymund Schwan France 22 213 0.2× 294 0.7× 332 0.9× 430 1.2× 198 0.8× 134 1.5k
Joseph P. Schacht United States 21 581 0.6× 1.0k 2.3× 712 1.8× 178 0.5× 189 0.8× 45 1.9k
Rebecca Crean United States 13 581 0.6× 412 0.9× 225 0.6× 133 0.4× 198 0.8× 17 1.1k
Simon Zhornitsky United States 26 293 0.3× 335 0.8× 625 1.6× 383 1.1× 244 1.0× 81 1.8k
Simona A. Stilo United Kingdom 17 511 0.6× 253 0.6× 173 0.4× 662 1.8× 382 1.6× 26 1.4k
Ion Anghelescu Germany 21 360 0.4× 354 0.8× 235 0.6× 557 1.6× 320 1.3× 54 1.6k
Kelly E. Courtney United States 22 310 0.3× 810 1.8× 613 1.6× 195 0.5× 296 1.2× 64 2.1k
Avi Reichenberg United States 14 394 0.4× 188 0.4× 320 0.8× 605 1.7× 234 1.0× 28 1.3k

Countries citing papers authored by Albert Batalla

Since Specialization
Citations

This map shows the geographic impact of Albert Batalla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Batalla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Batalla more than expected).

Fields of papers citing papers by Albert Batalla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Batalla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Batalla. The network helps show where Albert Batalla may publish in the future.

Co-authorship network of co-authors of Albert Batalla

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Batalla. A scholar is included among the top collaborators of Albert Batalla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Batalla. Albert Batalla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schwarzkopf, Larissa, et al.. (2024). Cannabis-related treatment demand at the eve of German cannabis legalization – a 20-years trend analysis. European Archives of Psychiatry and Clinical Neuroscience. 275(2). 365–378.
3.
Fortea, Adriana, Philip van Eijndhoven, Daniel Ilzarbe, et al.. (2023). Longitudinal Changes in Cortical Surface Area Associated With Transition to Psychosis in Adolescents at Clinical High Risk for the Disease. Journal of the American Academy of Child & Adolescent Psychiatry. 62(5). 593–600. 1 indexed citations
4.
Meer, Pim B. van der, Linda Dirven, Caroline Hertler, et al.. (2023). Depression and anxiety in glioma patients. Neuro-Oncology Practice. 10(4). 335–343. 19 indexed citations
5.
Bramness, Jørgen G., Marja Leonhardt, Geert Dom, et al.. (2023). Education and Training in Addiction Medicine and Psychology across Europe: A EUFAS Survey. European Addiction Research. 30(3). 127–137. 8 indexed citations
6.
Fortea, Adriana, Philip van Eijndhoven, Daniel Ilzarbe, et al.. (2023). Age-related change in cortical thickness in adolescents at clinical high risk for psychosis: a longitudinal study. European Child & Adolescent Psychiatry. 33(6). 1837–1846. 5 indexed citations
7.
Lähteenvuo, Markku, Jurjen J. Luykx, Heidi Taipale, et al.. (2022). Associations between antipsychotic use, substance use and relapse risk in patients with schizophrenia: real-world evidence from two national cohorts. The British Journal of Psychiatry. 221(6). 758–765. 17 indexed citations
8.
Pinzón-Espinosa, Justo, Marte van der Horst, Janneke Zinkstok, et al.. (2022). Barriers to genetic testing in clinical psychiatry and ways to overcome them: from clinicians’ attitudes to sociocultural differences between patients across the globe. Translational Psychiatry. 12(1). 442–442. 20 indexed citations
9.
Lähteenvuo, Markku, Albert Batalla, Jurjen J. Luykx, et al.. (2021). Morbidity and mortality in schizophrenia with comorbid substance use disorders. Acta Psychiatrica Scandinavica. 144(1). 42–49. 40 indexed citations
10.
Rossetti, Maria Gloria, Scott Mackey, Praveetha Patalay, et al.. (2021). Sex and dependence related neuroanatomical differences in regular cannabis users: findings from the ENIGMA Addiction Working Group. Translational Psychiatry. 11(1). 272–272. 17 indexed citations
11.
Fortea, Adriana, Albert Batalla, Joaquim Raduà, et al.. (2021). Cortical gray matter reduction precedes transition to psychosis in individuals at clinical high-risk for psychosis: A voxel-based meta-analysis. Schizophrenia Research. 232. 98–106. 16 indexed citations
12.
Batalla, Albert, et al.. (2021). The Impact of Cannabidiol on Human Brain Function: A Systematic Review. Frontiers in Pharmacology. 11. 618184–618184. 42 indexed citations
13.
Chye, Yann, Valentina Lorenzetti, Chao Suo, et al.. (2018). Alteration to hippocampal volume and shape confined to cannabis dependence: a multi‐site study. Addiction Biology. 24(4). 822–834. 32 indexed citations
14.
Chye, Yann, Chao Suo, Valentina Lorenzetti, et al.. (2018). Cortical surface morphology in long-term cannabis users: A multi-site MRI study. European Neuropsychopharmacology. 29(2). 257–265. 23 indexed citations
15.
Chye, Yann, Nadia Solowij, Eleni P. Ganella, et al.. (2017). Role of orbitofrontal sulcogyral pattern on lifetime cannabis use and depressive symptoms. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 79(Pt B). 392–400. 16 indexed citations
16.
Martial, Lisa C., Rob E. Aarnoutse, Arnt Schellekens, et al.. (2017). Dried Blood Spot sampling in psychiatry: Perspectives for improving therapeutic drug monitoring. European Neuropsychopharmacology. 27(3). 205–216. 30 indexed citations
17.
Batalla, Albert, Núria Bargalló, Patricia Gassó, et al.. (2015). Apoptotic markers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naive first-episode schizophrenia and healthy controls. Translational Psychiatry. 5(8). e626–e626. 27 indexed citations
19.
Barrio, Pablo, Albert Batalla, Pere Castellví, et al.. (2013). Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia. International Clinical Psychopharmacology. 28(4). 1–1. 23 indexed citations
20.
Martı́n-Santos, Rocı́o, José Alexandre S. Crippa, Albert Batalla, et al.. (2012). Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers. Current Pharmaceutical Design. 18(32). 4966–4979. 205 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026